Article
LY6G6D is Epigenetically Activated in Classical Colorectal Adenocarcinoma and Hyper-Methylated in Mucinous Subtypes Determining Resistance to FOLFOX Therapeutic Regimens.
2021-08-10
Abstract excerpt
<h4>Background: </h4> Colorectal cancer (CRC) represents a significant and ever-increasing societal threat and burden. Activation of Lymphocyte antigen 6G6D could induce anti-tumor specific immunity unique to CRC, but factors regulating its activation remain obscure. <h4>Methods: </h4>: Transcriptome, epigenome and proteomic data from TCGA and independent database were investigated using in silico approaches. Expr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4b19815b-cf56-50e4-bc21-beca37d9db5e
- DOI
- 10.21203/rs.3.rs-783534/v1
